Allogene Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
South San Francisco, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Allogene Therapeutics, Inc. has filed 570 SEC EDGAR filings since 19 Apr 2018

SEC filing history

Showing 126-150 of 570 matching filings.

Per page
25
Current page
6
4

FORM 4

Filing date
28 Jan 2025
Reporting date
24 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
28 Jan 2025
Reporting date
24 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
28 Jan 2025
Reporting date
24 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
28 Jan 2025
Reporting date
24 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
28 Jan 2025
Reporting date
24 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
28 Jan 2025
Reporting date
24 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
23 Jan 2025
Reporting date
21 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38693

144 filing

Filing date
21 Jan 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
10 Dec 2024
Reporting date
09 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
09 Dec 2024
Reporting date
05 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38693

144 filing

Filing date
09 Dec 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144/A File 001-38693

144/A filing

Filing date
04 Dec 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38693

144 filing

Filing date
02 Dec 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90685

SC 13G/A filing

Filing date
12 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90685

SC 13G/A filing

Filing date
08 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-90685

SC 13G filing

Filing date
04 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
23 Oct 2024
Reporting date
21 Oct 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90685

SC 13G/A filing

Filing date
22 Oct 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38693

144 filing

Filing date
21 Oct 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
23 Aug 2024
Reporting date
21 Aug 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .